Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.270
-0.020 (-0.87%)
Nov 5, 2024, 1:18 PM EST - Market open
Nuvation Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 34.29 | 42.65 | 101.1 | 132.42 | 29.76 | 3.47 | Upgrade
|
| Short-Term Investments | 542.88 | 568.56 | 559.92 | 632.97 | 186 | 115.4 | Upgrade
|
| Cash & Short-Term Investments | 577.17 | 611.21 | 661.01 | 765.39 | 215.75 | 118.87 | Upgrade
|
| Cash Growth | -8.52% | -7.53% | -13.64% | 254.76% | 81.50% | 86037.68% | Upgrade
|
| Other Receivables | 3.9 | 3.7 | 2.49 | 3.04 | 1.09 | 0.83 | Upgrade
|
| Receivables | 4.01 | 3.7 | 2.49 | 3.04 | 1.09 | 0.83 | Upgrade
|
| Prepaid Expenses | 5.99 | 1.52 | 3.82 | 3.64 | 0.91 | 0.19 | Upgrade
|
| Other Current Assets | - | - | - | - | 2.93 | - | Upgrade
|
| Total Current Assets | 587.17 | 616.43 | 667.32 | 772.07 | 220.68 | 119.89 | Upgrade
|
| Property, Plant & Equipment | 3.47 | 4.32 | 4.69 | 3.66 | 0.69 | 0.65 | Upgrade
|
| Other Long-Term Assets | 1.22 | 0.73 | 0.14 | 0.42 | 0.42 | 0.42 | Upgrade
|
| Total Assets | 594.8 | 621.48 | 672.14 | 776.15 | 221.79 | 120.95 | Upgrade
|
| Accounts Payable | 5.21 | 2.21 | 2.14 | 3.93 | 2.17 | 2.03 | Upgrade
|
| Accrued Expenses | 19.97 | 9.65 | 9.7 | 11.74 | 4.38 | 1.16 | Upgrade
|
| Short-Term Debt | 11.63 | - | - | - | - | - | Upgrade
|
| Current Portion of Leases | 2.08 | 1.97 | 1.21 | 0.86 | - | - | Upgrade
|
| Current Income Taxes Payable | - | 0.14 | 0.11 | 0.4 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.01 | Upgrade
|
| Total Current Liabilities | 51.1 | 13.97 | 13.16 | 16.93 | 6.55 | 3.2 | Upgrade
|
| Long-Term Leases | 0.97 | 2.04 | 3.05 | 2.19 | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.44 | 0.35 | 0.85 | 11.04 | 0.16 | - | Upgrade
|
| Total Liabilities | 62.67 | 16.36 | 17.07 | 30.15 | 6.71 | 3.2 | Upgrade
|
| Common Stock | 1,079 | 947.75 | 927.6 | 909.99 | 289.48 | 9.76 | Upgrade
|
| Retained Earnings | -820.09 | -342.8 | -267 | -162.8 | -75.96 | -34.3 | Upgrade
|
| Comprehensive Income & Other | -1.27 | 0.18 | -5.53 | -1.19 | 1.56 | 0.42 | Upgrade
|
| Total Common Equity | 257.19 | 605.12 | 655.08 | 746 | 215.08 | -24.12 | Upgrade
|
| Shareholders' Equity | 532.13 | 605.12 | 655.08 | 746 | 215.08 | 117.75 | Upgrade
|
| Total Liabilities & Equity | 594.8 | 621.48 | 672.14 | 776.15 | 221.79 | 120.95 | Upgrade
|
| Total Debt | 14.68 | 4.01 | 4.26 | 3.06 | - | - | Upgrade
|
| Net Cash (Debt) | 562.49 | 607.21 | 656.75 | 762.34 | 215.75 | 118.87 | Upgrade
|
| Net Cash Growth | -10.32% | -7.54% | -13.85% | 253.34% | 81.50% | - | Upgrade
|
| Net Cash Per Share | 2.50 | 2.77 | 3.03 | 3.85 | 2.21 | 0.58 | Upgrade
|
| Filing Date Shares Outstanding | 249.25 | 219.05 | 218.8 | 219.06 | 217.65 | 400 | Upgrade
|
| Total Common Shares Outstanding | 248.62 | 219.05 | 218.63 | 217.95 | 412.96 | 400 | Upgrade
|
| Working Capital | 536.08 | 602.46 | 654.16 | 755.15 | 214.13 | 116.68 | Upgrade
|
| Book Value Per Share | 1.03 | 2.76 | 3.00 | 3.42 | 0.52 | -0.06 | Upgrade
|
| Tangible Book Value | 254.26 | 605.12 | 655.08 | 746 | 215.08 | -24.12 | Upgrade
|
| Tangible Book Value Per Share | 1.02 | 2.76 | 3.00 | 3.42 | 0.52 | -0.06 | Upgrade
|
| Machinery | - | 1.04 | 1.04 | 0.83 | 0.56 | 0.49 | Upgrade
|
| Leasehold Improvements | - | 0.34 | 0.32 | 0.24 | 0.24 | 0.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.